LIPELLA PHARMACEUTICALS INC. (LIPO) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2024 | -$3.95M | -25.4% |
| 2023 | -$3.15M | -72.0% |
| 2022 | -$1.83M | -85.1% |
| 2021 | -$989.3K | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2024 | -$3.95M | -25.4% |
| 2023 | -$3.15M | -72.0% |
| 2022 | -$1.83M | -85.1% |
| 2021 | -$989.3K | — |